DE69001739D1 - Fluessige, wasserhaltige ophthalmische zusammensetzung von fluessig-gel-phasenuebergangstyp. - Google Patents

Fluessige, wasserhaltige ophthalmische zusammensetzung von fluessig-gel-phasenuebergangstyp.

Info

Publication number
DE69001739D1
DE69001739D1 DE9090311208T DE69001739T DE69001739D1 DE 69001739 D1 DE69001739 D1 DE 69001739D1 DE 9090311208 T DE9090311208 T DE 9090311208T DE 69001739 T DE69001739 T DE 69001739T DE 69001739 D1 DE69001739 D1 DE 69001739D1
Authority
DE
Germany
Prior art keywords
liquid
phase transition
gel phase
ophthalmic composition
water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE9090311208T
Other languages
English (en)
Other versions
DE69001739T2 (de
Inventor
Gilles Chastaing
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Laboratories Merck Sharp and Dohme Chibret SAS
Original Assignee
Laboratories Merck Sharp and Dohme Chibret SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Laboratories Merck Sharp and Dohme Chibret SAS filed Critical Laboratories Merck Sharp and Dohme Chibret SAS
Publication of DE69001739D1 publication Critical patent/DE69001739D1/de
Application granted granted Critical
Publication of DE69001739T2 publication Critical patent/DE69001739T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE90311208T 1989-10-17 1990-10-12 Flüssige, wasserhaltige ophthalmische Zusammensetzung von Flüssig-Gel-Phasenübergangstyp. Expired - Lifetime DE69001739T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8913534A FR2653021A1 (fr) 1989-10-17 1989-10-17 Composition ophtalmique aqueuse liquide a transition de phase liquide-gel.

Publications (2)

Publication Number Publication Date
DE69001739D1 true DE69001739D1 (de) 1993-07-01
DE69001739T2 DE69001739T2 (de) 1993-11-25

Family

ID=9386463

Family Applications (1)

Application Number Title Priority Date Filing Date
DE90311208T Expired - Lifetime DE69001739T2 (de) 1989-10-17 1990-10-12 Flüssige, wasserhaltige ophthalmische Zusammensetzung von Flüssig-Gel-Phasenübergangstyp.

Country Status (9)

Country Link
EP (1) EP0424043B1 (de)
JP (1) JP3043795B2 (de)
AT (1) ATE89745T1 (de)
CA (1) CA2027630C (de)
DE (1) DE69001739T2 (de)
DK (1) DK0424043T3 (de)
ES (1) ES2055339T3 (de)
FR (1) FR2653021A1 (de)
IE (1) IE64045B1 (de)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2594486B2 (ja) * 1991-01-15 1997-03-26 アルコン ラボラトリーズ インコーポレイテッド 局所的眼薬組成物
JP2536806B2 (ja) * 1991-03-27 1996-09-25 アルコン ラボラトリーズ インコーポレイテッド ゲル化多糖類と微粉砕された薬剤担体とを組み合わせた局部眼科用組成物
US5422116A (en) * 1994-02-18 1995-06-06 Ciba-Geigy Corporation Liquid ophthalmic sustained release delivery system
US6261547B1 (en) 1998-04-07 2001-07-17 Alcon Manufacturing, Ltd. Gelling ophthalmic compositions containing xanthan gum
US6174524B1 (en) 1999-03-26 2001-01-16 Alcon Laboratories, Inc. Gelling ophthalmic compositions containing xanthan gum
AU8008300A (en) 1999-11-01 2001-05-14 Alcon Inc. Pharmaceutical compositions containing a fluoroquinolone antibiotic drug and xanthan gum
PT1305033E (pt) 2000-07-28 2005-01-31 Alcon Inc Composicoes farmaceuticas que contem tobramicina e goma de xantano
PE20020578A1 (es) 2000-10-10 2002-08-14 Upjohn Co Una composicion de antibiotico topico para el tratamiento de infecciones oculares
WO2002040056A2 (en) 2000-11-06 2002-05-23 Alcon, Inc Carrageenan viscoelastics for ocular surgery
CA2477044A1 (en) 2002-02-22 2003-09-04 Pharmacia Corporation Ophthalmic formulation with gum system
US20080131454A1 (en) * 2006-12-05 2008-06-05 Marinomed Biotechnologie Gmbh Methods and Compositions for the Treatment of Rhinovirus Infections with Carrageenan
WO2011018800A2 (en) 2009-08-13 2011-02-17 Fdc Limited A novel in-situ gel forming solution for ocular drug delivery
HUE044329T2 (hu) * 2014-01-22 2019-10-28 Visufarma B V Iota-karragént tartalmazó készítmény vírusos kötõhártya-gyulladás ellen
PT3370692T (pt) * 2015-07-14 2023-07-18 Marinomed Biotech Ag Composição que elimina a congestão nasal e possui atividade antiviral
CN109752557B (zh) * 2017-11-06 2021-06-08 清华大学 检测生物分子间相互作用及其调控因子的成套试剂与应用
DE202022102900U1 (de) 2022-05-25 2023-01-13 Anant Narayanrao Deshpande Tetrahydrocurcumin niosomales in-situ-Gel für okulare Arzneimittelabgabe

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4136173A (en) * 1977-01-31 1979-01-23 American Home Products Corp. Mixed xanthan gum and locust beam gum therapeutic compositions
FR2542616B1 (fr) * 1983-03-17 1987-07-31 Unilever Nv Composition pour le traitement des muqueuses a base d'un antibiotique et d'un hydrocolloide formateur de gel
US4717713A (en) * 1983-10-31 1988-01-05 Research Corporation Controlled release liquid pharmaceutical
FR2588189B1 (fr) * 1985-10-03 1988-12-02 Merck Sharp & Dohme Composition pharmaceutique de type a transition de phase liquide-gel
DE3601132A1 (de) * 1986-01-16 1987-07-23 Christian Bannert Verfahren zur behandlung der schleimhaut
GB2203039B (en) * 1987-03-02 1990-10-24 American Cyanamid Co Stable ophthalmic preparations containing acetazolamide

Also Published As

Publication number Publication date
IE903713A1 (en) 1991-04-24
IE64045B1 (en) 1995-06-28
DK0424043T3 (da) 1993-06-21
FR2653021A1 (fr) 1991-04-19
DE69001739T2 (de) 1993-11-25
ATE89745T1 (de) 1993-06-15
EP0424043A1 (de) 1991-04-24
ES2055339T3 (es) 1994-08-16
JP3043795B2 (ja) 2000-05-22
CA2027630C (en) 2001-04-24
JPH03133936A (ja) 1991-06-07
EP0424043B1 (de) 1993-05-26
CA2027630A1 (en) 1991-04-18

Similar Documents

Publication Publication Date Title
DE69001739D1 (de) Fluessige, wasserhaltige ophthalmische zusammensetzung von fluessig-gel-phasenuebergangstyp.
DK183386A (da) Sucralfatsuspension
FR2634799B1 (fr) Composition aqueuse pour l'assouplissement de textiles, et procede utilisant cette composition
NO890113L (no) Vannloeselig polymer, saerlig for vaskemidler.
NL300389I1 (nl) Thiofeensulfonamiden die bruikbaar zijn als carbo-anhydraseremmers.
DE69019205D1 (de) Bohrlochbehandlungsflüssigkeit, enthaltend vernetzbare Zellulosederivate.
DK570587D0 (da) Stabiliseret enzymsystem til anvendelse i vandige, flydende builderholdige rensemidler
ATE118966T1 (de) Landmaschine mit verbesserter aufhängungsvorrichtung der arbeitswerkzeugeeinheit.
SE9002522D0 (sv) Metod foer framstaellning av en farmaceutisk komposition i form av mikropartiklar
NO894963L (no) Flytende vaskemiddel, samt fremgangsmaate for dets fremstilling.
IT8720059A0 (it) Process per la preparazione di (2,2)-paraciclofano e suoi derivati.
IT8819077A0 (it) Processo per la preparazione di 1,2 difluoroetano e di 1,1,2trifluoroetano.
DK318088D0 (da) Vaeskeformig, vandig detergentsammensaetning og fremgangsmaade til fremstilling af samme
IT8620939A0 (it) Processo per la preparazione di (2,2)-paraciclofano e suoi derivati.
TR26910A (tr) Konsantre, sulu sivi deterjan bilesimleri.
DE69636953D1 (de) Lyophilisierte hgf-zubereitungen
DE58903477D1 (de) Fluessige, strahlenhaertbare ueberzugsmasse fuer die beschichtung von glasoberflaechen.
ATE193287T1 (de) Herstellung von derivaten von a-acetyl neuraminicsäuren
NL157598B (nl) Werkwijze voor de bereiding van optische bleekmiddelen, afgeleid van 4,4'-bis-(2",4"-diamino-s-triazinyl(6")-amino)-stilbeen-2,2'-disulfonzuur, werkwijze voor het optisch bleken, voorwerpen verkregen onder toepassing van deze werkwijze, alsmede werkwijze voor de bereiding van geconcentreerde vloeibare preparaten.
DE68919518D1 (de) Eingekapselte, flüssige Detergenszusammensetzung.
ATE162188T1 (de) Herstellung von derivaten von n-acetyl neuraminicsäure
NO178028C (no) Fremgangsmåte ved fremstilling av 3-(L-pyroglutamyl)-L-tiazolidin-4-karboksylsyre samt derivater derav
ATE139560T1 (de) Wässerige zeolithsuspension, die ein silikonat enthält
FR2698371B1 (fr) Procede de preparation de la forme leuco de colorants au soufre sous forme de particules.
IT1227787B (it) Oxo isoindolinil derivati otticamente attivi.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: LABORATOIRES MERCK SHARP & DOHME-CHIBRET SNC, PARI